Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Gonorrhea Figures

thumbnail of Figure 14 Figure 14. Gonorrhea—Rates, United States, 1941–2009

thumbnail of Figure 15 Figure 15. Gonorrhea—Rates by Sex, United States, 1990–2009

thumbnail of Figure 16 Figure 16. Gonorrhea—Rates by Region, United States, 2000–2009

thumbnail of Figure 17 Figure 17. Gonorrhea—Rates by State, United States and Outlying Areas, 2009

thumbnail of Figure 18 Figure 18. Gonorrhea—Rates by County, United States, 2009

thumbnail of Figure 19 Figure 19. Gonorrhea—Rates by Age and Sex, United States, 2009

thumbnail of Figure 20 Figure 20. Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2000–2009

thumbnail of Figure 21 Figure 21. Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2000–2009

thumbnail of Figure 22 Figure 22. Gonorrhea—Rates by Race/Ethnicity, United States, 2000–2009

thumbnail of Figure 23 Figure 23. Gonorrhea—Cases by Reporting Source and Sex, United States, 2000–2009

thumbnail of Figure 24 Figure 24. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2009

thumbnail of Figure 25 Figure 25. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2009

thumbnail of Figure 26 Figure 26. Gonococcal Isolate Surveillance Project (GISP)—Location of Participating Sentinel Sites and Regional Laboratories, United States, 2009

thumbnail of Figure 27 Figure 27. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Ceftriaxone Among GISP Isolates, 2005–2009

thumbnail of Figure 28 Figure 28. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Cefixime Among GISP Isolates, 2005–2006 and 2009

thumbnail of Figure 29 Figure 29. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Azithromycin Among GISP Isolates, 2005–2009

thumbnail of Figure 30 Figure 30. Gonococcal Isolate Surveillance Project (GISP)—Percentage of Neisseria gonorrhoeae Isolates with Resistance or Intermediate Resistance to Ciprofloxacin, 1990–2009

thumbnail of Figure 31 Figure 31. Gonococcal Isolate Surveillance Project (GISP)—Penicillin, Tetracycline, and Ciprofloxacin Resistance Among GISP Isolates, 2009

thumbnail of Figure 32 Figure 32. Gonococcal Isolate Surveillance Project (GISP)—Drugs Used to Treat Gonorrhea Among GISP Participants, 1988–2009


View all Gonorrhea figures as a slideshow[PPT 1.63MB]

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #